A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis.
Luca StingeniLeonardo BianchiElettra AntonelliElena Sofia CaroppoSilvia Mariel FerrucciCarlotta GurioliMichela OrtoncelliGabriella FabbrociniEustachio NettisDonatella SchenaMaddalena NapolitanoMassimo GolaLaura BonzanoMariaTeresa RossiAnna Belloni FortinaAnna BalatoKetty PerisCaterina FotiFabrizio GuarneriMarco RomanelliCataldo PatrunoPaola SavoiaMaria EspositoFilomena RussoEnzo ErrichettiTommaso BianchelliLuca BianchiGiovanni PellacaniClaudio FelicianiAnnamaria OffidaniMonica CorazzaGiuseppe MicaliNicola MilanesiGiovanna MalaraAndrea ChiricozziMarta TramontanaKatharina Hanselnull nullPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)